Skip to main content
. 2021 Jun 26;22(13):6879. doi: 10.3390/ijms22136879

Figure 4.

Figure 4

EGCG administration reduced GFAP and Iba-1 activation: Immunohistochemical analysis of GFAP: sham (A), vehicle 24 h (B), EGCG 24 h (C), vehicle three days (D), EGCG three days (E), vehicle five days (F), EGCG five days (G). Immunohistochemical analysis of Iba-1: sham (H), vehicle 24 h (I), EGCG 24 h (J), vehicle three days (K), EGCG three days (L), vehicle five days (M), EGCG five days (N). A p-value of less than 0.05 was considered significant.